Amavita Xylo Plus Nasenspray
Amavita Xylo Plus Nasenspray is a medicine authorised by Swissmedic under authorisation number 68071. The authorisation holder is Amavita Health Care AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 23 September 2020 and the authorisation is valid without a time limit. ATC code R01AB06 places the medicine in the group Nasal preparations.
| Authorisation number | 68071 |
|---|---|
| Name | Amavita Xylo Plus Nasenspray |
| Full name | Amavita Xylo Plus Nasenspray, Lösung |
| Authorisation holder | Amavita Health Care AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R01AB06 |
| First authorisation | 23 September 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Amavita Xylo Plus Nasenspray, Lösung | D | 23 September 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | ml | R01AB06 | 12.02.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amavita Xylo Plus Nasenspray authorised in Switzerland?
Yes. Amavita Xylo Plus Nasenspray is authorised by Swissmedic under authorisation number 68071, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amavita Xylo Plus Nasenspray have?
Amavita Xylo Plus Nasenspray is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Amavita Xylo Plus Nasenspray?
The authorisation holder is Amavita Health Care AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.